Studies on 5-fluoro-.ALPHA.-methyltryptamine and p-chloro-.BETA.-methylphenethylamine: Determination of the MAO-A or MAO-B selective inhibition in vitro.
Author(s) -
Hiroyasu Kinemuchi,
Yuichiro Arai,
Yoshie Toyoshima,
Takeshi Tadano,
Kensuke Kisara
Publication year - 1988
Publication title -
the japanese journal of pharmacology
Language(s) - English
Resource type - Journals
eISSN - 1347-3506
pISSN - 0021-5198
DOI - 10.1254/jjp.46.197
Subject(s) - in vitro , in vivo , non competitive inhibition , chemistry , stereochemistry , alpha (finance) , inhibitory postsynaptic potential , pharmacology , biochemistry , enzyme , biology , medicine , surgery , construct validity , microbiology and biotechnology , patient satisfaction
To further clarify highly MAO-A- or -B-selective inhibitory properties of 5-fluoro-alpha-methyltryptamine (5-FMT) and p-chloro-beta-methylphenethylamine (p-CMPEA), we determined the types and K1 values of inhibition of rat brain MAO-A and -B activity in vitro. The kinetic data obtained showed that 5-FMT is a competitive MAO-A-selective inhibitor with about a 18,000-fold higher sensitivity than MAO-B. In contrast, p-CMPEA is a competitive MAO-B-selective inhibitor with about a 620-fold higher sensitivity. Based on the present findings of highly MAO-A- or -B-selective inhibition, these two compounds might prove to be of value in in vivo studies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom